Abstract Objective: To assess the clinical efficacy and safety of short-term glucocorticoid therapy in patients with early- or pre-stage hepatitis B virus (HBV)-related liver failure. Methods: We retrospectively analyzed 143 patients with early- or pre-stage HBV-related liver failure treated at our center between January 2015 and December 2025. Of these, 43 received methylprednisolone conventional therapy (glucocorticoid group) and 100 received conventional therapy alone (conventional group).
Fengjun Liu
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Fengjun
Contact Fengjun, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack